Siglyn M 100/1000 Tablet ER
Marketer
Zydus Healthcare Limited
Salt Composition
Sitagliptin (100mg) + Metformin (1000mg)
Overview Siglyn M 100/1000 Tablet ER
Duo-Med 100/1000 Extended-Release tablets manage elevated blood glucose in type 2 diabetes patients by combining two active ingredients. This dual action helps avert severe diabetic complications like renal impairment and vision loss, potentially lowering heart attack and stroke risks. Duo-Med 100/1000 ER may be used independently or in conjunction with other anti-diabetic therapies. Optimal results require adherence to a balanced diet and regular physical activity. Dosage is personalized based on your health status, blood glucose readings, and existing medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under your physician's guidance. Continued commitment to your prescribed diet and exercise plan is crucial for diabetes management. Lifestyle choices significantly impact diabetes control. Common side effects include nausea, diarrhea, vomiting, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential side effect, especially when combined with insulin or sulfonylureas; learn to recognize and manage this. This medication isn't for everyone. Inform your doctor of any history of kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption before starting treatment. Pregnant or lactating individuals should seek medical advice. Interactions with other medications are possible; disclose all medications to ensure safety. Alcohol should be limited due to its hypoglycemic effect. Your doctor will monitor your renal function and blood sugar levels throughout your treatment.
Uses of Siglyn M 100/1000 Tablet ER
Managing type 2 diabetes
Major Benefits of Siglyn M 100/1000 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Siglyn M 100/1000 Tablet ER. Ingest the tablet whole; do not crush, chew, or divide it. Administer this extended-release medication with a meal.
Common Side effects of Siglyn M 100/1000 Tablet ER:
- Decreased appetite
- Vomiting
- Upper respiratory tract infection
- Hypoglycemia (low blood glucose level)
- Abdominal bloating
- Nausea
- Diarrhea
How to use Siglyn M 100/1000 Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Siglyn M 100/1000 Tablet ER whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.
How Siglyn M 100/1000 Tablet ER works:
Siglyn M 100/1000 Extended-Release tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin secretion from the pancreas, improves insulin utilization, and decreases hepatic glucose production. Metformin, a biguanide, reduces liver glucose output, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action optimizes blood sugar regulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Siglyn M 100/1000 Tablet ER and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Extended-release Siglyn M 100/1000 tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Siglyn M 100/1000 tablets are likely not safe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Siglyn M 100/1000 ER tablets; dosage modification may be necessary. Consult your physician. Siglyn M 100/1000 ER tablets are contraindicated in patients with severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverUNSAFE
Extended-release Siglyn M 100/1000 tablets pose a likely risk for individuals with hepatic impairment and are best avoided. Physician consultation is recommended.
What if you forget to take Siglyn M 100/1000 Tablet ER :
Should you forget to take a Siglyn M 100/1000 Extended-Release tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Siglyn M 100/1000 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |



